QRxPharma defendants can access class members’ broker details

Class Actions 2018-09-13 11:49 pm | Sydney
The defendants in a shareholder class action over QRxPharma’s alleged failure to disclose problems with regulatory approval for its painkiller Moxduo have won access to information on class members’ financial brokers.
For information on rights and reprints, contact subscriptions@lawyerly.com.au